News|Articles|September 27, 2013

Catalent Applied Drug Delivery Institute Appoints New Advisory Board Member

Author(s)Melanie Sena

Catalent Applied Drug Delivery Institute appoints Claus-Michael Lehr to advisory board.

The Catalent Applied Drug Delivery Institute, an institute formed by Catalent Pharma Solutions, to promote collaboration between industry and academia, provide applied drug-delivery education and training, and advanced drug delivery, has appointed Claus-Michael Lehr, Head of the Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Germany and Co-founder and Head of the Department “Drug Delivery” of the Helmholtz Institute for Pharmaceutical Research Saarlandto the institute’s advisory board.

Professor Lehr has t more than 15 years researching ways to overcome biological barriers to effective drug delivery and the development and formulation of appropriate carriers to transport active pharmaceutical and biopharmaceutical molecules to desired targets. He has co-authored many publications on the development of sophisticated in-vitro models that represent the epithelial cells and tissues concerned in transport, and the application of nanotechnology to improve in-vivo delivery to such therapeutic targets.

Source: Catalent


Related to this article

FDA
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
Quality inspector walking through processing area with stainless tanks and tablet | Image Credit: ©Surachai -stock.adobe.com
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.